PAS
PROK icon

Point72 Asia (Singapore)’s ProKidney PROK Stock Holding History

Point72 Asia (Singapore)’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-66,281
Closed -$39.2K – 1181
2025
Q2 		$39.2K Buy
+66,281
New +$51.6K 0.01% 642

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Asia (Singapore)'s PROK Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of ProKidney (PROK) in Q3 2025, closing a stake of 66,281 shares — an estimated $39.2K sold.

Point72 Asia (Singapore) first reported a position in PROK in Q2 2025 and held it in 1 quarter. The position peaked at $39.2K in Q2 2025. 56 funds tracked by Wall St. Rank hold PROK as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining ProKidney position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 66,281 ProKidney shares in Q3 2025, an estimated $39.2K.
  • Point72 Asia (Singapore) first reported a position in ProKidney in Q2 2025 and held it in 1 quarter.
  • Point72 Asia (Singapore)'s ProKidney position peaked at $39.2K in Q2 2025.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.